Francesco Grandesso, MSF

Slides:



Advertisements
Similar presentations
Risk factors and true outcomes of children lost to follow-up from antiretroviral therapy in Lilongwe, Malawi C. Ardura Gracia, H. Tweya, C Feldacker, S.
Advertisements

Most deaths among children enrolled in two program settings in Cambodia occur within the first 6 months after enrolment. Early mortality rates were more.
Ebola Virus Disease, West Africa outbreak 2014 An update on cases 21/04/2015 To update slides with most recent figures, please follow links and instructions.
BHIVA national clinical audit of HIV diagnosis Dr Margaret Johnson, Chair of BHIVA clinical audit committee Dr Gary Brook Vice-Chair of BHIVA clinical.
Rashid A. Chotani, MD, MPH Adjunct Professor, GWU
Preliminary findings of a routine PMTCT Option B+ programme in a rural district in Malawi Rebecca M. Coulborn 1, Laura Triviño Duran 1, Carol Metcalf 2,
Introduction DCDOH supports HIV test and treat activities - increased number of HIV tests performed, emphasis on earlier linkage to care. Limited data.
Cardiovascular Morbidity Following Modern Treatment for Hodgkin Lymphoma: Age- and Sex- Specific Estimates of Risk in the Doxorubicin Era. D. Hodgson 1,
Linkage between SSCAS data and mortality data. Patients’ outcome Determined by: Prior health and personal characteristics Severity of illness Effectiveness.
Neisseria meningitides outbreak-Harenabuluk District, Ethiopia,2011 Yembo Gole Ejeta 1, Fikire Bulti 2 an Kebabe Tolasa 3 1 Addis Ababa University, 2 Oromia.
Catherine Kober Margaret Johnson Martin Fisher Caroline Sabin On behalf of UK-CHIC BHIVA/BASHH Manchester 2010 Non-uptake of HAART among patients with.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
The indirect effects of Ebola to the health system in Sierra Leone A.J. van Duinen 1,2, A. Erikson 3,4, A.M. Ekström 3, K. Brolin 3,4, H.A. Bolkan 1,2,5.
Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.
Liberia Field Epidemiology Training Programme (LFETP)Liberia Field Epidemiology Training Programme LFETP) FIELD WORK 2 -Expanded Surveillance Report- -Case.
1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.
Effect of ART on malaria parasitaemia and clinical episodes in adults in rural Uganda: A population-based cohort study Billy N. Mayanja 1, Kathy Baisley.
STUDENT RESEARCH PROJECT Faculty of Medical Sciences The University of the West Indies St. Augustine Assessing Quality of Life (QOL) among People Living.
When Using DOPPS Slides. DOPPS Slide Use Guidelines.
WILLIAM N. MKANTA, PH.D. WESTERN KENTUCKY UNIVERSITY Study of Prostate Cancer Screening and Mortality in Blacks and Whites.
PJ Devereaux, MD, PhD McMaster University
J. Mossong1, N. Majéry2, C. Mardaga3 , M. Muller4, F. Schneider1
- Higher SBP visit-to-visit variability (SBV) has been associated
1University of Kentucky, Lexington, Kentucky
US cost-effectiveness of simvastatin in 20,536 people at different levels of vascular disease risk: randomised placebo-controlled trial UK Medical Research.
Blood, birthing and body fluids:
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
CMV viraemia and 12-week mortality among hospitalised adults with HIV-associated TB in Khayelitsha Hospital, South Africa: A prospective cohort study A.
Implementation of home-based insulin management (HIM) without refrigeration in Dagahaley refugee camp, Kenya Said Abdullahi Hassan1, Abdijabir Adan1,
Aminu M and Okpe Sunday Ejeh
Factors affecting virological failure in patients receiving antiretroviral therapy: a prospective HIV Clinical cohort in rural Uganda. Patrick Kazooba1,
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Dr Wail Said Ali ,Dr Yassir Abdlrahman Dr Husham Abdlrahmen, Farooq A
Colin Fischbacher Information Services Division (ISD)
Ebola Virus Table Top Exercise
L.F. Jefferys1, J. Hector1, M.A. Hobbins2, J. Ehmer2, N. Anderegg3
Polypharmacy and specific medication profiles as predictors of treatment and health outcomes in dementia Dr Christoph Mueller, NIHR Academic Clinical Lecturer.
Prognosis of younger patients in non-small cell lung cancer
Clinical outcome after SVR: Veterans Affairs
A COLLABORATIVE APPROACH TO ESTABLISH PREDICTORS
San Francisco Department of Public Health
INDIRECT STANDARDIZATION BY MBBSPPT.COM
Content Public Health Emergencies Ebola Virus Disease: DRC
EBOLA VIRUSES (SYMPTOMS, TREATMENT AND CAUSES) Nama : Siti Sofea Annisa Binti Sheikh Mohamad No. Matric : Lecturer : Madam Siti Wahida Binti.
JIT: Ebola Weekly Update 21 January, 2015 Lets Beat Ebola in 2015
Update on EVD Epidemiological Situation in Sierra Leone And Guinea WHO Country Office Liberia 20 February 2015.
Extended ART Initiation Criteria Can Be Implemented Successfully in Rural South Africa Sarah Jane Steele1, Gemma Arellano2, Tom Ellman3, Amir Shroufi1,
DIRECÇÃO PROVINCIAL DE SAÚDE TETE
24 July 2018 Treatment outcomes with bedaquiline use when substituted for second-line injectables in multidrug resistant tuberculosis: a retrospective.
Date: Presenter: Ryan Chen
JIT: Ebola Weekly Update 04 December, 2014
Ebola: worldwide dissemination risk and response priorities
THE SPERM ACROSOME REACTION RESPONSE TO PROGESTERONE ASSOCIATED WITH SPERM DNA DAMAGE HAS A BETTER PREDICTING VALUE FOR IVF THAN THAT RESPONSE TO THE IONOPHORE.
the case of five large hospitals in Rome, Italy
وضعیت موجود مرگ و میر و علل مرگ غیر مادری در افراد سال کارشناس اداره سلامت میانسالان معصومه آرشین چی همدان 27 و 28 تیرماه 1396.
JIT: Ebola Weekly Update 11 December, 2014
Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study  Ousmane Faye, PhD, Pierre-Yves Boëlle,
Malaria morbidity and mortality in Ebola-affected countries caused by decreased health- care capacity, and the potential effect of mitigation strategies:
Values in Health Policy
Clinical trials to try to find an effective treatment for Ebola patients are to start in West Africa next month. The medical charity Medecins Sans Frontières,
Baseline Demographic Characteristics of Adults With Diagnosed Heart Failure and Eligible to Receive Lipid-Lowering Therapy Alan S. Go, et al.
Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014–15 Ebola virus disease response:
Baseline characteristics of older women (NHS I), younger women (NHS II), and men (HPFS) with a history of hypertension according to thiazide use Eric N.
Simvastatin in Patients With Prior Cerebrovascular Disease: HPS
The impact of living in an Ebola-affected household on food insecurity and quality of life in Kono District, Sierra Leone: a cross-sectional study two.
Characteristics of 3415 patients admitted to hospital with
Clinical Microbiology and Infection
MSM Attending STD Clinics HIV Testing More Frequently: Implications for HIV Prevention and Surveillance D Helms1, H Weinstock1, K Mahle1, A Shahkolahi1,2,
Share your thoughts on this presentation with #IAS2019
Presentation transcript:

Francesco Grandesso, MSF Patient characteristics and risk of mortality in the Médecins Sans Frontières Ebola Management Centres (EMCs) during the West African Ebola outbreak - Preliminary Analysis Francesco Grandesso, MSF

Objectives Provide an overall description of Ebola virus confirmed patients admitted in MSF main EMCs: age, sex, time to admission, case fatality rate (CFR) Provide a preliminary analysis of the risk factors for death among confirmed and admitted patients

Freetown/Kissy 08-01-15 to 07-03-15 Conakry/Donka 25-03-14 to 12-04-15 Magburaka 15-12-14 to 28-03-15 Freetown/Pow 10-12-14 to 20-02-15 Guéckédou 21-03-14 to 09-02-15 Kailahun 26-06-14 to 22-02-15 Freetown/Kissy 08-01-15 to 07-03-15 Foya 26-06-14 to 13-02-15 Monrovia/Elwa 3 16-08-14 to 24-03-15 Bo 19-09-14 to 16-03-15

Patients admitted to MSF EMCs Patients (up to 12th of April 2015) Country Centre Admitted Confirmed % Guinea Gueckedou 1635 1074 65.7 Donka 1940 779 40.2 Sierra Leone Kailahun 1219 857 70.3 Bo 483 443 91.7 Freetown 401 170 42.4 Magburaka 136 46 33.8 Kissy 102 24 23.5 Liberia Foya 695 384 55.3 Monrovia-ELWA3 1909 1241 65.0 All centres 8520 5018 58.9

Methodology Pooling of 9 MSF EMC line-lists: 5 in Sierra Leone, 2 in Liberia and 2 in Guinea Descriptive analysis of main patient characteristics at admission Incidence rate ratios (IRR) from univariate and multivariate poisson regression analyses adjusted for intra and inter-variation among EMC to explore factors associated with risk of dying: age groups, sex, month of admission, time to admission, and cycle threshold at admission as proxy of viral load

Overall patient characteristics Age (years) n % <5 279 5.6 5-14 693 14.0 15-54 3549 71.6 55+ 437 8.8 Sex Female 2543 50.7 Male 2472 49.3 Time to admission (days) n % 0-3 1645 35.3 4-7 2130 45.7 8-13 675 14.5 14+ 212 4.5

Case fatality by centre EMC Cases Deaths CFR % Risk ratio [95% CI] Gueckedou 1069 618 57.8 1.00 – Donka 723 342 47.3 0.81 [0.74-0.89] Kailahun 853 390 45.7 0.79 [0.72-0.86] Bo 441 171 38.8 0.67 [0.59-0.76] Freetown 166 83 50.0 0.85 [0.72-1.00] Magburaka 44 21 47.7 [0.59-1.11] Kissy 22 14 63.6 1.01 [0.72-1.43] Foya 381 228 59.8 1.04 [0.94-1.14] Monrovia-ELWA3 1204 690 57.3 0.97 [0.90-1.04] All centres 4903 2557 52.2

Changes in case fatality over time

Case fatality according to patients’ age

Factors associated with death (all centres)   Univariate analysis Multivariate analysis Admitted Died % IRR [95% CI] Month of admission – 0.96 [0.94–0.99] Age (years) <5 264 180 68.2 2.00 [1.65–2.41] 2.11 [1.73–2.58] 5-14 677 281 41.5 1.00 15-54 3348 1705 50.9 1.38 [1.22–1.57] 1.35 [1.19–1.55] 55+ 399 273 68.4 2.22 [1.87–2.62] 2.21 [1.85–2.63] Time to admission (days) 0-3 1529 835 54.6 4-7 2053 1051 51.2 1.01 [0.92–1.11] 1.02 [0.93–1.12] 8-13 655 313 47.8 1.03 [0.90–1.17] [0.88–1.15] 14+ 212 98 46.2 1.10 [0.89–1.35] 1.08 [0.87–1.34] Sex Female 2396 1210 50.5 Male 2344 1265 54.0 1.11 [1.02–1.20] [1.02–1.21]

Cycle threshold associated with death

Factors associated with death   Univariate analysis Multivariate analysis Admitted Died % IRR [95% CI] Month of admission – 0.93 [0.90–0.96] Age (years) <5 176 120 68.2 1.96 [1.57–2.45] 1.82 [1.43–2.30] 5-14 520 215 41.3 1.00 15-54 2471 1259 51.0 1.37 [1.19–1.59] [1.18–1.59] 55+ 287 204 71.1 2.30 [1.89–2.78] 2.06 [1.69–2.51] Time to admission (days) 0-3 1131 634 56.1 4-7 1557 803 51.6 0.98 [0.89–1.09] 1.04 [0.94–1.16] 8-13 473 225 47.6 0.96 [0.83–1.13] 1.14 [0.97–1.33] 14+ 152 66 43.4 [0.74–1.24] 1.20 [0.93–1.55] Cycle threshold <18 517 474 91.7 7.29 [6.28–8.46] 7.28 [6.24–8.50] 18-22 1009 642 63.6 2.40 [2.14–2.69] 2.47 [2.19–2.79] 22+ 1969 711 36.1 Sex Female 1789 918 51.3 Male 1703 906 53.2 1.05 [0.96–1.15] 1.06 [0.96–1.17]

Limitations Limited factors explored (i.e. clinical symptoms at admission and exposure/epidemiological link analysis not incorporated) Limited to patients admitted (community deaths and deaths on arrival not included) Time to admission questioned Pooling of data from various contexts Different laboratories and assays for Ebola PCR (and possibly used/reported antigens)

Discussion-Conclusion Cycle threshold at admission the main predictor of death Higher risk of death in relation to younger and older age Death incidence rate decreases with time passing independently from the factors analysed Symptoms at admission, treatment provided during the course of hospitalisation, workload in the EMC, distance to EMC, as well as factors associated with higher viral load should be further investigated

Acknowledgments All MSF volunteers and local staff who work and have been working in the field All epidemiologists and medical referents in the field and in MSF headquarters